OncLive: Dr. Loeb on the Impact of Additional Testing for Prostate Cancer (published Oct 11, 2017)
OncLive: Dr. Loeb on the Impact of Additional Testing for Prostate Cancer (published Oct 11, 2017)
Washington, DC . October 4-7, 2017 Lecture Topic: Women in science panel, poster on crowdfunding in prostate cancer Category: Women in science, Social Media
Loeb S, Curnyn C, Fagerlin A, Braithwaite RS, Schwartz MD, Lepor H, Carter HB, Sedlander E. “Informational needs during active surveillance for prostate cancer: A qualitative study.” Patient Education Counseling 2017 Sep 1 epub. PMID: 28886974 Link: https://www.ncbi.nlm.nih.gov/pubmed/28886974
Loeb S, Zhou Q, Siebert U, Rochau U, Jahn B, Mühlberger N, Carter HB, Lepor H, Braithwaite RS. “Active Surveillance Versus Watchful Waiting for Localized Prostate Cancer: A Model to Inform Decisions”. European Urology 2017 Aug 22 epub. PMID: 28844371 Link: https://www.ncbi.nlm.nih.gov/pubmed/28844371 We designed a Markov model showing that active surveillance extends life more than… Read More
OncLive: Dr Loeb on the Results of Active Surveillance for Prostate Cancer (published August 2017)
Dani H, Loeb S. “The Role of Prostate Cancer Biomarkers in Undiagnosed Men.” Current Opinion Urology 2017; 27: 210-216. PMID 28212119 Link: https://www.ncbi.nlm.nih.gov/pubmed/28212119
Liss MA, Ehdaie B, Loeb S, Meng MV, Raman JD, Spears V, Stroup SP. “An Update of the American Urological Association White Paper on the Prevention and Treatment of the More Common Complications Related to Prostate Biopsy.” Journal of Urology 2017 Mar 29 epub. PMID: 28363690 Link: https://www.ncbi.nlm.nih.gov/pubmed/28363690 This is an updated American Urological… Read More
Loeb S, Peskoe SB, Joshu CE, Huang WY, Hayes RB, Carter HB, Isaacs WB, Platz EA “Do Environmental Factors Modify the Genetic Risk of Prostate Cancer?” Cancer Epidemiology Biomarkers Prevention 2015; 24: 213. PMID: 25342390. Link: http://www.ncbi.nlm.nih.gov/pubmed/25342390 This study examined effect modification by environmental factors of the association between single nucleotide polymorphisms with prostate… Read More
Loeb S, Folkvaljon Y, Damber JE, Alukal J, Lambe M, Stattin P. “Testosterone Replacement Therapy and Risk of Favorable and Aggressive Prostate Cancer.” Journal of Clinical Oncology 2017;35(13):1430-1436. PMID: 28447913. Link: https://www.ncbi.nlm.nih.gov/pubmed/28447913
Loeb S. “Biomarkers for Prostate Biopsy and Risk Stratification of Newly Diagnosed Prostate Cancer Patients.” Urology Practice. 2017 Jul;4(4):315-321. PMID: 29104903 Link: https://www.ncbi.nlm.nih.gov/pubmed/29104903
Loeb S, Ross AE. “Genomic testing for localized prostate cancer: where do we go from here?” Current Opinion in Urology. 2017 Jun 28 epub. PMID: 28661898 Link: https://www.ncbi.nlm.nih.gov/pubmed/28621058
St, Louis, Missouri. June 9, 2017 Lecture Topic: Social media in urology Category: Social media
Loeb S, Ross AE. “Genomic testing for localized prostate cancer: where do we go from here?” Current Opinion in Urology. 2017 Jun 28 epub. PMID: 28661898 Link: https://www.ncbi.nlm.nih.gov/pubmed/28661898
OncLive: Dr Loeb on Tests for the Management of Prostate Cancer (published June 6, 2017) https://www.youtube.com/watch?v=RexdoXUbF98
OncLive: Dr. Loeb on Tests for the Management of Prostate Cancer (published June 6, 2017)
Philadelphia, Pennsylvania. May 18, 2017 Lecture Topic: Biomarkers in the diagnosis and management of localized prostate cancer Category: Prostate Cancer
OncLive: Dr Loeb on Active Surveillance for Prostate Cancer (published May 12, 2017)
01/2016 Lecture on “When to Biopsy: The Role for PSA and Novel Biomarkers” at the International Prostate Cancer Update in Vail, Colorado (January 2016)
Prostate Cancer Foundation: Women in Prostate Cancer Research- Dr Stacy Loeb (published March 17, 2017) https://www.youtube.com/watch?v=PJIEald08kU&t=37s
Prostate Cancer Foundation: Women in Prostate Cancer Research- Dr Stacy Loeb (published March 17, 2017
Loeb S, Meyer C, Krasnova A, Curnyn C, Reznor G, Lepor H, Kibel AS, Trinh QD. “Risk of Small Bowel Obstruction After Robot-Assisted Versus Open Radical Prostatectomy.” Journal of Endourology 2016 Sep 11 epub. PMID: 27615204 Link: https://www.ncbi.nlm.nih.gov/pubmed/27615204
Seoul, Korea. October 12-15, 2016 Lecture Topics: Prostate Cancer Markers, Active Surveillance, BPH Category: Prostate Cancer, Benign Prostatic Hyperplasia
Mony Tremblant, Canada. January 19-21, 2017 Lecture Topics: Prostate Cancer Markers, Active Surveillance, Prostate Biopsy Category: Prostate Cancer
Acapulco, Mexico. February 3-4, 2017 Lecture Topics: Prostate Cancer Screening, Prostate Biopsy, Prostate MRI, Active Surveillance, Radical Prostatectomy, Radiation Therapy Category: Prostate Cancer
Nickel JC, Gorin MA, Alan W P, Loeb S, Ellen S, Chancellor MB, Assimos DG, Brawer MK, Brucker BM. “Best of the 2016 AUA Annual Meeting: Highlights From the 2016 American Urological Association Annual Meeting, May 6-10, 2016, San Diego, CA.” Reviews in Urology 2016;18(3):159-173. PMID: 27833468. Link: https://www.ncbi.nlm.nih.gov/pubmed/27833468
Choyke PL and Loeb S. “Active Surveillance of Prostate Cancer.” Oncology (Williston Park) 2017; 31 (1). PMID 8090626 Link: https://www.ncbi.nlm.nih.gov/pubmed/28090626
Loeb S, Curnyn C, Fagerlin A, Braithwaite RS, Schwartz MD, Lepor H, Carter HB, Sedlander E. “A Qualitative Study on Decision-Making by Prostate Cancer Physicians during Active Surveillance.” BJU International. 2016 epub. PMID: 27611479. Link: https://www.ncbi.nlm.nih.gov/pubmed/27611479
Loeb S, Folkvaljon Y, Curnyn C, Robinson D, Bratt O, Stattin P. “Uptake of Active Surveillance for Very-Low-Risk Prostate Cancer in Sweden”. JAMA Oncology. 2016 Oct 20. PMID: 27768168. Link: https://www.ncbi.nlm.nih.gov/pubmed/27768168 Using nationwide Sweden data, this study showed that by 2014, active surveillance was selected by 91% of very low risk, 74% of low risk… Read More
Loeb S. “When is a Negative Prostate Biopsy Really Negative? Repeat Biopsies in Detection and Active Surveillance.” Journal of Urology 2017 epub. PMID 28110035 Link: https://www.ncbi.nlm.nih.gov/pubmed/28110035
Thomsen FB, Folkvaljon Y, Brasso K, Loeb S, Robinson D, Egevad L, Stattin P. “Prognostic implications of 2005 Gleason grade modification. Population-based study of biochemical recurrence following radical prostatectomy.” Journal of Surgical Oncology. 2016 Aug 11 epub. PMID: 27511833. Link: https://www.ncbi.nlm.nih.gov/pubmed/27511833
Loeb S, Shin SS, Broyles DL, Wei JT, Sanda M, Klee G, Partin AW, Sokoll L, Chan DW, Bangma CH, van Schaik RH, Slawin KM, Marks LS, Catalona WJ. “Prostate Health Index improves multivariable risk prediction of aggressive prostate cancer” BJU International. 2016 Oct 15. PMID:27743489 Link: https://www.ncbi.nlm.nih.gov/pubmed/27743489
Crawford ED, Rosenberg MT, Partin AW, Cooperberg MR, Maccini M, Loeb S, Pettaway CA, Shore ND, Arangua P, Hoenemeyer J, Leveridge M, Leapman M, Pinto P, Thompson IM Jr, Carroll P, Eastham J, Gomella L, Klein EA. “An Approach Using PSA Levels of 1.5 ng/mL as the Cutoff for Prostate Cancer Screening in Primary Care.” Urology…. Read More
Dr Stacy Loeb hosts the Men’s Health Show on US/Canada Satellite Radio (SiriusXM Channel 110) on Wednesdays from 6-8pmEST. Next shows: August 30, September 27, October 25
Lake Tahoe (Northstar, California). January 28-30, 2017 Lecture Topics: Urology Highlights of 2016 as Seen Through the Eyes of Twitter, What Has Happened to Screening for Prostate Cancer in the US? Categories: Social Media, Prostate Cancer